DECHRA PHARMACEUTICALS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,866 GBX | -.--% |
|
-.--% | +0.21% |
Presenter SpeechIan Page (Executives)Good morning, everybody. Thanks for your time this mornin...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows:
- companion animal products (74.6%);
- food producing animal products (11.5%);
- equine health products (7.3%);
- animal feeds (5.1%);
- other (1.5%): products manufactured by third parties.
Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Sector
-
- Stock Market
- Equities
- DPH Stock
- News Dechra Pharmaceuticals
- Transcript : Dechra Pharmaceuticals PLC, H1 2023 Earnings Call, Feb 27, 2023
